title: Little evidence that cholinesterase inhibitors prevent progression of mild cognitive impairment to dementia, but they are associated with adverse effects.
authors.affiliation: Schlegel Research Chair in Geriatric Pharmacotherapy Schlegel-UW Research Institute on Ageing & School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada. carlos.rojas-fernandez@uwaterloo.ca
authors.forename: Carlos H
authors.initials: CH
authors.lastname: Rojas-Fernandez